
Integrating ESR1m Testing and Novel Oral SERDS Into Multidisciplinary Workflows: Regional Guidance for HR+, HER2- Advanced Breast Cancer
Please visit answersincme.com/860/101707775-replay2 to participate, download slides and supporting materials, complete the post test, and get a certificate. [Presented by Erika Hamilton, MD, FASCO; Komal Jhaveri, MD, FACP, FASCO; and John Allen Piede, MD. In this activity, experts in breast cancer provide a practical, community-focused discussion on integrating ESR1 mutation testing, applying emerging data on novel endocrine therapies, such as SERDs, and personalizing treatment strategies for patients with HR+, HER2− advanced breast cancer. Upon completion of this activity, participants should be better able to: Integrate testing for ESR1 mutations at appropriate times into practice workflows in the treatment of...
Publisher
CME in Minutes: Education in Oncology & Hematology
Link
answersincme.com/860/101707775-replay2
Published
August 4, 2026
Duration
1h 3m
Format
Podcast
Category
Lifestyle · Medicine
Source
RSS feed
Host
Answers in CME
CME in Minutes: Education in Oncology & Hematology
@cmeinminuteseducationinoncol
#integratingesr1mtesting #noveloralserds #advancedbreastcancer #lifesciences #medicine
